Maria F. Theodoulou

Oncology

1275 York Ave
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 25, 2019

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 13, 2016

A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.

A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.

Journal: Clinical breast cancer

Published: June 18, 2015

Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review.

Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review.

Journal: NPJ breast cancer

Published: January 20, 2015

Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 31, 2014

Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention study.

Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention study.

Journal: Cancer

Published: November 17, 2011

Showing 1-6 of 6

Last Updated: 09/26/2026